On August 6, Hebo Pharmaceutical announced the appointment of Zhang Baohong as the president of the Metabolism Division. Zhang Baohong will be based in Shanghai and will report directly to Wang Jinsong, founder, chairman and CEO of Hebo Pharmaceuticals. As the president of the Metabolism Division, Zhang Baohong will be fully responsible for the division's strategy formulation and daily operation, coordinating pipeline layout, R&D promotion, organizational construction, strategic cooperation, and NewCo incubation to accelerate the promotion of transformative treatment plans to benefit patients.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.